At Charlottesville Veterinary Hospital, we understand that pet owners may have concerns regarding the safety of new treatments for their furry companions. Recently, the FDA has shared findings about potential adverse side effects linked to Librela, a monoclonal antibody therapy designed to manage osteoarthritis (OA) in dogs. We want to provide transparent information to help you make informed decisions about your pet’s health.

What is Librela?

Librela is a monthly injectable treatment that targets nerve growth factor (NGF) to alleviate the pain associated with osteoarthritis. This innovative therapy aims to improve mobility and reduce discomfort for dogs suffering from joint issues.

Understanding the FDA Findings

While Librela has been shown to provide significant relief for many dogs, the FDA has reported cases of adverse side effects in some pets. Common side effects may include lethargy, mild gastrointestinal issues, or localized reactions at the injection site. In rare cases, more serious side effects, such as hypersensitivity reactions, have been observed.

For more details, you can review the official FDA findings on Librela here. Additionally, Zoetis has responded to these concerns and provided further information on Librela’s safety, which you can read here.

What Should Pet Owners Know?

  • Monitor Your Pet: After receiving a Librela injection, keep a close eye on your dog for any unusual behavior or symptoms. Contact your veterinarian if you notice signs of discomfort, swelling, or decreased energy.
  • Discuss Your Concerns: If you’re worried about potential risks, don’t hesitate to discuss your pet’s medical history with your veterinarian. Librela may not be suitable for dogs with specific health conditions or sensitivities.
  • Balanced Decision-Making: The benefits of pain relief and improved mobility often outweigh the risks for many pets. However, every dog is different, and it is important to weigh the pros and cons based on your pet’s unique needs.

Why Consider Librela Despite the Findings?

  • Targeted Pain Relief: Librela directly blocks pain signals without affecting other bodily systems, which can be beneficial compared to traditional pain medications.
  • Reduced Dependence on NSAIDs: For dogs that cannot tolerate NSAIDs, Librela provides an alternative path to pain management.
  • Improved Quality of Life: Many dogs experience increased activity levels and greater comfort with Librela, enhancing their overall well-being.

Partnering with Pet Owners for Safe Treatment

At Charlottesville Veterinary Hospital, we prioritize safety and transparency in every aspect of pet care. If your dog has been diagnosed with osteoarthritis and you’re considering Librela, we will work closely with you to monitor their response and address any concerns promptly.

Have Questions?

We are here to help. Schedule a consultation to discuss Librela, review FDA findings, and explore the best options for your pet’s health and happiness. Your pet’s well-being is our top priority.